These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36788096)

  • 1. Genomic Profiling With Large-Scale Next-Generation Sequencing Panels Distinguishes Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases.
    Yang CY; Yeh YC; Wang LC; Lin YY; Lin SY; Wang SY; Chu PY; Liu ZY; Su YC; Ho HL; Chou TY
    Mod Pathol; 2023 Mar; 36(3):100047. PubMed ID: 36788096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach.
    Chang JC; Alex D; Bott M; Tan KS; Seshan V; Golden A; Sauter JL; Buonocore DJ; Vanderbilt CM; Gupta S; Desmeules P; Bodd FM; Riely GJ; Rusch VW; Jones DR; Arcila ME; Travis WD; Ladanyi M; Rekhtman N
    Clin Cancer Res; 2019 Dec; 25(23):7113-7125. PubMed ID: 31471310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel NGS-based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients.
    Zhang X; Fan X; Sun C; Wang L; Miao Y; Wang L; Yang P; Xu Y; Ren X; Wu X; Xu S
    J Pathol Clin Res; 2023 Mar; 9(2):108-120. PubMed ID: 36579550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold standard?
    Araujo-Filho JAB; Chang J; Mayoral M; Plodkowski AJ; Perez-Johnston R; Lobaugh S; Zheng J; Rusch VW; Rekhtman N; Ginsberg MS
    Lung Cancer; 2021 Mar; 153():158-164. PubMed ID: 33529990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of next-generation sequencing in distinguishing between separate primary lung carcinomas and intrapulmonary metastasis: A case report.
    Mantri SS; Wallace WD; Nieva JJ
    Thorac Cancer; 2024 Aug; ():. PubMed ID: 39139011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does histological assessment accurately distinguish separate primary lung adenocarcinomas from intrapulmonary metastases? A study of paired resected lung nodules in 32 patients using a routine next-generation sequencing panel for driver mutations.
    Bruehl FK; Doxtader EE; Cheng YW; Farkas DH; Farver C; Mukhopadhyay S
    J Clin Pathol; 2022 Jun; 75(6):390-396. PubMed ID: 33649140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors.
    Mansuet-Lupo A; Barritault M; Alifano M; Janet-Vendroux A; Zarmaev M; Biton J; Velut Y; Le Hay C; Cremer I; Régnard JF; Fournel L; Rance B; Wislez M; Laurent-Puig P; Herbst R; Damotte D; Blons H
    J Thorac Oncol; 2019 May; 14(5):844-856. PubMed ID: 30721797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
    Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
    J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases.
    Belardinilli F; Pernazza A; Mahdavian Y; Cerbelli B; Bassi M; Gradilone A; Coppa A; Pignataro MG; Anile M; Venuta F; Della Rocca C; Giannini G; d'Amati G
    Pathol Res Pract; 2021 Apr; 220():153387. PubMed ID: 33647865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas.
    Ezer N; Wang H; Corredor AG; Fiset PO; Baig A; van Kempen LC; Chong G; Issac MSM; Fraser R; Spatz A; Riviere JB; Broët P; Spicer J; Camilleri-Broët S
    Cancer Treat Res Commun; 2021; 29():100484. PubMed ID: 34773797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic Assessment and Staging of Multiple Non-Small Cell Lung Carcinomas: A Paradigm Shift with the Emerging Role of Molecular Methods.
    Chang JC; Rekhtman N
    Mod Pathol; 2024 May; 37(5):100453. PubMed ID: 38387831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung.
    Nicholson AG; Torkko K; Viola P; Duhig E; Geisinger K; Borczuk AC; Hiroshima K; Tsao MS; Warth A; Lantuejoul S; Russell PA; Thunnissen E; Marchevsky A; Mino-Kenudson M; Beasley MB; Botling J; Dacic S; Yatabe Y; Noguchi M; Travis WD; Kerr K; Hirsch FR; Chirieac LR; Wistuba II; Moreira A; Chung JH; Chou TY; Bubendorf L; Chen G; Pelosi G; Poleri C; Detterbeck FC; Franklin WA
    J Thorac Oncol; 2018 Feb; 13(2):205-217. PubMed ID: 29127023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation sequencing facilitates differentiating between multiple primary lung cancer and intrapulmonary metastasis: a case series.
    Liu C; Liu C; Zou X; Shao L; Sun Y; Guo Y
    Diagn Pathol; 2021 Mar; 16(1):21. PubMed ID: 33706781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
    Dacic S; Cao X; Bota-Rabassedas N; Sanchez-Espiridion B; Berezowska S; Han Y; Chung JH; Beasley MB; Dongmei L; Hwang D; Mino-Kenudson M; Minami Y; Papotti M; Rekhtman N; Roden AC; Thunnissen E; Tsao MS; Yatabe Y; Yoshida A; Wang L; Hartman DJ; Jerome JA; Kadara H; Chou TY; Wistuba II;
    J Thorac Oncol; 2024 Feb; 19(2):273-284. PubMed ID: 37717856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
    Drilon A; Wang L; Arcila ME; Balasubramanian S; Greenbowe JR; Ross JS; Stephens P; Lipson D; Miller VA; Kris MG; Ladanyi M; Rizvi NA
    Clin Cancer Res; 2015 Aug; 21(16):3631-9. PubMed ID: 25567908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations.
    Hu Y; Ren S; Chen C; Liang Q; Yu F; Liu W
    Thorac Cancer; 2020 Jul; 11(7):2018-2022. PubMed ID: 32415761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series.
    Ericson-Lindquist K; Johansson A; Levéen P; Elmberger G; Jönsson G; Staaf J; Brunnström H
    Diagn Pathol; 2017 Mar; 12(1):31. PubMed ID: 28347348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
    Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
    Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous Pulmonary Adenocarcinomas.
    Pagan CA; Shu CA; Crapanzano JP; Lagos GG; Stoopler MB; Rizvi NA; Heymann JJ; Sonett JR; Fernandes H; Saqi A
    Am J Clin Pathol; 2020 Jun; 154(1):57-69. PubMed ID: 32146481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.